May 08, 2025

Early Menopause Linked to Long-Term Cognitive Decline, Study

A large UK-based cohort study found that early menopause—before age 40—is associated with both higher depressive symptoms and worse cognitive function over time.

Conexiant

May 08, 2025

Diet Patterns Affect Menarche Timing

New research reveals healthier diets delay menarche while inflammatory diets accelerate it, potentially impacting long-term health outcomes in women regardless of BMI.

Conexiant

May 08, 2025

Doctors Gas Up Vulvovaginal Patients: Study

New research reveals over 50% of patients with vulvovaginal disorders considered abandoning care due to dismissive clinician behaviors, with many reporting their symptoms were disbelieved or trivialized.

Conexiant

May 01, 2025

FDA Approves Intranasal DHE for Acute Migraine Relief

The FDA has approved Atzumi for the acute treatment of migraine with or without aura in adults.

Conexiant

April 28, 2025

More Menopause Symptoms, Greater Cognitive Risk

Study demonstrates dose-dependent relationship: each additional menopausal symptom associated with poorer cognitive function and increased behavioral changes in later life.

Conexiant

April 28, 2025

Oral Contraceptives Linked to Gut Gas Shifts

Researchers found oral contraceptives alter gut bacteria and breath gas levels differently depending on menstrual cycle timing.

Conexiant

April 25, 2025

WHI Funding Restored After Uproar

"We are now working to fully restore funding to these essential research efforts."

Conexiant

April 25, 2025

FDA Approves Penpulimab-kcqx for NPC

The FDA approved penpulimab-kcqx for first line and previously treated recurrent or metastatic non-keratinizing nasopharyngeal carcinoma.

Conexiant

April 24, 2025

FDA Warns of Topical Finasteride Risks

The FDA has issued a safety alert on compounded topical finasteride products, citing adverse events and emphasizing the lack of regulatory approval or safety evaluation.

Conexiant